medpagetoday news

In Autosomal Dominant Polycystic Kidney Disease, What Indicates Progression?

A Japanese study examined differences in total kidney volume and total liver volume in patients with autosomal dominant polycystic kidney disease receiving either peritoneal dialysis or hemodialysis. Some findings were unexpected.

Treating UTIs in Polycystic Kidney Disease


In ADPKD, Making the Most of CT/MRI


In ADPKD, Match the Blood Pressure to the Individual


Screening for Cerebral Aneurysm in ADPKD

medpagetoday news

Genetic Testing In ADPKD: It’s Getting Easier

David Charytan, MD, MSc, of NYU Grossman School of Medicine, describes the evolving landscape of genetic testing in polycystic kidney disease and why it's useful. (2:12)

Q&A: Rupesh Raina, MBBS, on the Cardiovascular Implications of Hypertensive ADPKD

Dr. Raina discusses his recent review and meta-analysis on cardiovascular pathologies in patients with ADPKD in an interview with MedPage Today.

In Autosomal Dominant Polycystic Kidney Disease, Using Exome Sequencing to Aid Diagnosis

This study demonstrated substantial genetic and phenotype variability in ADPKD among patients, which researchers propose could be used as a tool for ADPKD diagnosis.

Kidney and Liver Volumetry: Deep-Learning Model Enables Accurate Segmentation

A deep-learning model for fully automated joint kidney and liver segmentation was recently shown to be a robust and accurate tool for rapid estimation of kidney and liver volume. But is it feasible to implement it into routine clinical care?

Q&A: Dinushika Mohottige, MD and Lisa McElroy, MD on ADPKD Health Inequities

Drs. Mohottige and McElroy comment about factors that may contribute to prevalent racial and ethnic disparities in ADPKD outcomes, as well as possible ways to achieve equity in ADPKD care.

In ADPKD, What Are the Risk Factors for Intracranial Aneurysm?

According to a new study from Tokyo, decline in kidney function and increased kidney volume may be risk factors for intracranial aneurysm in patients with autosomal dominant polycystic kidney disease.

In Autosomal Dominant Polycystic Kidney Disease, What are the Risk Factors for Disease Progression?

Korean investigators sought to identify risk factors associated with ADPKD progression. A standard therapy for slowing the advance to end stage renal disease is lacking.
medpagetoday news

National Registry Provides Insights into Autosomal Dominant Polycystic Kidney Disease

The Polycystic Kidney Disease Foundation established the first national ADPKD Registry to facilitate therapeutic research on ADPKD, which has been limited by lack of an organized patient database.